1-6 of 6
Annamaria Naggi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo

Maura Poli, Michela Asperti, Annamaria Naggi, Natascia Campostrini, Domenico Girelli, Michela Corbella, Marina Benzi, Celine Besson-Fournier, Helene Coppin, Federica Maccarinelli, Dario Finazzi, Paolo Arosio
Journal: Blood
Blood (2014) 123 (10): 1564–1573.
https://doi.org/10.1182/blood-2013-07-515221
Published: 2014
Includes: Supplemental data
Journal Articles

Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity

Maura Poli, Domenico Girelli, MD, Annamaria Naggi, Natascia Campostrini, PhD, Dario Finazzi, Federica Maccarinelli, Annalisa Castagna, Paolo Arosio, Ph.D.
Journal: Blood
Blood (2012) 120 (21): 483.
https://doi.org/10.1182/blood.V120.21.483.483
Published: 2012
Journal Articles

Anti-Heparanase Therapy in Combination with Conventional Chemotherapy Potently Inhibits Multiple Myeloma Growth in Vivo

Joseph P. Ritchie, Annamaria Naggi, Giangiacomo Torri, Benito Casu, Claudio Pisano, Paolo Carminati, Israel Vlodavsky, Ralph D. Sanderson, Yang Yang
Journal: Blood
Blood (2008) 112 (11): 5165.
https://doi.org/10.1182/blood.V112.11.5165.5165
Published: 2008
Journal Articles

The Heparanase Inhibitor SST0001 Is a Potent Inhibitor of Myeloma Growth In Vivo

Yang Yang, Joseph P. Ritchie, Telisha Swain, Annamaria Naggi, Giangiacomo Torri, Benito Casu, Claudio Pisano, Paolo Carminati, Israel Vlodavsky, Ralph D. Sanderson
Journal: Blood
Blood (2008) 112 (11): 246.
https://doi.org/10.1182/blood.V112.11.246.246
Published: 2008
Journal Articles

A Heparin-Based Inhibitor of Heparanase Blocks Myeloma Growth In Vivo by Targeting the Tumor Microenvironment.

Yang Yang, MD, PhD, Telisha Swain, BA, Annamaria Naggi, PhD, Giangiacomo Torri, PhD, Benito Casu, PhD, Israel Vlodavsky, PhD, Ralph D. Sanderson, PhD
Journal: Blood
Blood (2007) 110 (11): 1502.
https://doi.org/10.1182/blood.V110.11.1502.1502
Published: 2007
Journal Articles

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

Yang Yang, Veronica MacLeod, Yuemeng Dai, Yekaterina Khotskaya-Sample, Zachary Shriver, Ganesh Venkataraman, Ram Sasisekharan, Annamaria Naggi, Giangiacomo Torri, Benito Casu, Israel Vlodavsky, Larry J. Suva, Joshua Epstein, Shmuel Yaccoby, John D. Shaughnessy, Jr, Bart Barlogie, Ralph D. Sanderson
Journal: Blood
Blood (2007) 110 (6): 2041–2048.
https://doi.org/10.1182/blood-2007-04-082495
Published: 2007